Web16 mei 2024 · About Medicenna Medicenna is a clinical stage immunotherapy company developing novel highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs). WebMedicenna Therapeutics Corp. (Translation of registrant's name into English) 2 Bloor St. W., 7th Floor Toronto, Ontario M4W 3E2, Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ ] Form 40-F [ X ]
Medicenna Therapeutics Corp. (MDNA.TO) Stock Price, News, …
Web14 mrt. 2024 · In doing so, they become powerful and proprietary tools called Superkines that can modulate, fine-tune and empower the immune system to fight cancer, autoimmune and neuroinflammatory diseases. NASDAQ: MDNA TSX: MDNA NASDAQ: MDNA $0.54 0 (0.00%) Data Provided by Refinitiv. Minimum 15 minutes delayed. Events March 14, … Web17 mrt. 2024 · Detailed statistics for Medicenna Therapeutics Corp. ... financial numbers, share information and more. Detailed statistics for Medicenna Therapeutics Corp. (MDNA) stock, including valuation metrics, financial numbers, share information and more. ... The stock price has decreased by -56.61% in the last 52 weeks. lawyers in fort worth texas
Medicenna Therapeutics - MDNA Stock Forecast, Price
WebMedicenna Therapeutics Corp. analyst ratings, historical stock prices, earnings estimates & actuals. MDNA updated stock price target summary. Web14 apr. 2024 · MDNA stock forecast for 2024 – 2027. Last updated: February 20, 2024. MDNA. Medicenna Therapeutics Corp. 0.6600 D 1.54% (0.0100) WebGet Medicenna Therapeutics Corp (MDNA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Skip Navigation. ... Shares Out 69.64M; 10 Day … lawyers in frederick md